Director Brennan Alice C bought 19 RCG shares at $2.63; insider's 3 prior buys at ticker all showed +2.6% to +47.0% 90-day returns; 5 other insiders also bought in past 14 days
Brennan's purchase of 19 shares at $2.63 continues a consistent pattern of well-timed buying activity at RCG. Her 3 prior trades at this ticker were all well-timed purchases, with 90-day returns of +12.4%, +2.6%, and positive outcomes ranging from +28.4% to +47.0%, demonstrating reliable execution in identifying entry points. The clustering of 5 other insider purchases within the past 14 days suggests coordinated or independently-observed conviction about valuation at current levels near $2.62. This adds credibility to the director's judgment, as the pattern reflects not just individual timing skill but broader insider perspective on the company's position.
Director Brennan Alice C buys 100 HKHC shares at $38.00; track record shows 100% 90d win rate across 5 prior buys (avg +38.8%), and 2 prior HKHC buys both timed profitably (90d: +56.5%, +59.7%).
Director Brennan Alice C purchased 100 shares at $38.00, increasing holdings by 11.1% to 1,000 shares. Her cross-ticker open-market track record is notably strong: 5 prior buys averaged a 90-day return of +38.8% with a 100.00% win rate, demonstrating consistent timing accuracy. At this same ticker (HKHC), she has executed 2 prior purchases on 2024-09-06 and 2024-09-03, both of which posted strong 90-day gains (+56.5% and +59.7% respectively), indicating an established pattern of well-timed accumulation at this company. The current $38.00 price is -28.3% from the 52-week high of $53.00, and fundamentals show a company in transition: FY revenue growth of +1580.3% but a net loss of $-10.5M against quarterly revenue of $19.8M. This purchase pattern—an experienced director with a proven 90-day timing record accumulating at a lower valuation following sharp recent declines—aligns with her historical approach, though near-term price headwinds (-2.9% in 30 days) remain.
Director Brennan Alice C buys 16 RCG shares at $2.51; prior 2 RCG buys both gained 28.4%–47.0% in 90d, plus cluster of 3 insiders buying within 14 days
Brennan Alice C purchased 16 shares of RENN Fund, Inc. at $2.51 on 2024-12-26, a small absolute addition but adding to her 2,334 prior shares. Her prior two open-market purchases at RCG (on 2024-08-26 and 2024-08-21) each produced strong 90-day returns of 47.0% and 28.4% respectively, both posted gains within three months. Coinciding with this transaction, 3 other insiders also bought within the past 14 days, creating a cluster buy pattern that reduces the risk this is an isolated or routine rebalancing move. While the current price of $2.57 sits 6.6% below the 30-day baseline and -7.2% from the 52-week high, the stock is +20.7% over 90 days, suggesting a sustained recovery phase that aligns with her historical execution at this ticker.
Director Brennan Alice C buys 400 shares at $25.56; stock at $24.00 post-listing; 3 other insiders buying concurrently
Brennan Alice C purchased 400 shares at $25.56 on 2024-09-06, three trading days after Horizon Kinetics Holding Corp's public listing. The transaction increased her holdings by 80.0%, raising her stake to 900 shares from 500. The current price of $24.00 is below the purchase price, placing her underwater on this new position. Critically, this buy occurs within a cluster pattern: 3 other insiders also purchased within the past 14 days. In the context of a newly listed company with severe fundamentals (Annual revenue growth of -79.5%, net income of $-450,000.00 on quarterly revenue of $718,000.00, and a P/E of 800.00), coordinated insider accumulation immediately post-IPO warrants close examination of whether management believes the stock is mispriced or whether other undisclosed factors underpin these concurrent purchases.
Director Brennan Alice C bought 500 HKHC shares at $24.36; cluster pattern with 2 other insiders in 14 days amid -79.5% revenue decline
Director Brennan Alice C purchased 500 shares at $24.36 on 2024-09-03, establishing an initial position. This transaction is part of a cluster pattern: 2 other insiders also bought within the past 14 days. The timing is notable given the company's financial backdrop—latest quarterly revenue stands at $718.0K with net income of -$450.0K, and annual revenue has contracted by -79.5%. The synchronized buying activity by multiple insiders during a period of significant operational headwinds warrants attention to whether this reflects insider perspective on valuation or strategic positioning.
Director Brennan Alice C purchased 500 RCG shares at $1.84 on 2024-08-26, raising holdings to 2,334 shares (+27.3%)
Alice C Brennan, a director, purchased 500 shares at $1.84 on 2024-08-26 for $918.30, the second purchase at RCG within five trading days (after acquiring 30 shares on 2024-08-21). The purchases occurred as the stock was trading near its 52-week high of $1.89, having already risen 16.9% over 90 days and 5.6% over the past month. Across the insider's broader trading history, this represents just her second open-market buy; however, no measurable 90-day outcome is yet available from her prior RCG transaction. The rapid succession of two purchases suggests accumulation activity, though the lack of historical context at this specific ticker and the stock's already-elevated position relative to its annual range limit the ability to assess timing conviction.
Director Brennan Alice C purchases 500 RCG shares at $1.83, raising stake to 1,834 shares (+37.5%)
Director Brennan purchased 500 shares of RENN Fund, Inc. (RCG) at $1.83 on 2024-08-21, increasing her holdings from 1,334 to 1,834 shares—a 37.5% increase in her position. The purchase occurred near the midpoint of the 52-week range of $1.55–$1.89, with the stock subsequently rising 2.8% over 30 days and 14.6% over 90 days, now trading at $1.85 (2.1% below the 52-week high). The transaction represents a modest absolute acquisition ($915.00 total value) in a closed-end fund with limited absolute price movement, providing a limited dataset for pattern assessment.
